Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study of Male Osteoporosis and Aging
This study is currently recruiting participants.
Verified by Odense University Hospital, December 2006
Sponsors and Collaborators: Odense University Hospital
Novo Nordisk
AP Moeller Foundation
Information provided by: Odense University Hospital
ClinicalTrials.gov Identifier: NCT00463411
  Purpose

The aim of this study is to identify potential risk factors for fragility fractures in men.


Condition
Osteoporosis

MedlinePlus related topics: Osteoporosis
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Random Sample, Prospective Study
Official Title: Study on Male Osteoporosis and Aging

Further study details as provided by Odense University Hospital:

Estimated Enrollment: 30000
Study Start Date: December 2006
Estimated Study Completion Date: December 2017
Detailed Description:

Osteoporosis is a disease characterized by decreased bone mass and pathological changes in the microarchitecture of the bones. The clinical significance of osteoporosis is the association with fragility fractures and, consequently, increases in both morbidity and mortality.

In men, genetical and life-style factors are known to affect the risk of fractures, however, data relating these factors with measures of bone mineral density and fracture risk are limited.

30.000 men aged 60-70 were randomly selected from the Central Office of Civil Registration in Denmark. Each receive a questionnaire addressing demographics, potential risk factors of osteoporosis, past medical history and medication by mail. In case of consent, the participants will complete a full medical examination including DXA and sampling of DNA if they have a fragility fracture. At the same time, 2 participants from the study population will be selected as control. The study period is 10 years.

  Eligibility

Ages Eligible for Study:   60 Years to 70 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Men aged 60-70 being able to consent in writing
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00463411

Contacts
Contact: Kim T Brixen, MD, Ph.d 0045 65413536 KBR33.OUHADM-POST@ouh.fyns-amt.dk
Contact: Morten F Nielsen, MD 0045 22877448 frostnielsen@yahoo.com

Locations
Denmark
Department of Endocrinology Recruiting
Odense, Denmark, 5000
Contact: Morten F Nielsen, MD     0045 22877448 ext 65413536     frostnielsen@yahoo.com    
Contact: Kim T Brisen, MD, Ph.d.     0045 65413536     KBR33.OUHADM-POST@ouh.fyns-amt.dk    
Sponsors and Collaborators
Odense University Hospital
Novo Nordisk
AP Moeller Foundation
Investigators
Principal Investigator: Kim T Brixen, MD. Ph.d Odense University Hospital
  More Information

Study ID Numbers: 025
Study First Received: April 18, 2007
Last Updated: April 19, 2007
ClinicalTrials.gov Identifier: NCT00463411  
Health Authority: Denmark: National Board of Health

Keywords provided by Odense University Hospital:
osteoporosis
male
fracture risk
genetical epidemiology

Study placed in the following topic categories:
Musculoskeletal Diseases
Fractures, Bone
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

ClinicalTrials.gov processed this record on January 16, 2009